Summit Therapeutics Inc.
SMMT
$15.12
$0.251.65%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 61.87% | -201.09% | -258.11% | -312.05% | -836.84% |
| Total Depreciation and Amortization | 24.32% | 76.00% | 90.91% | 110.00% | 85.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -86.23% | 769.77% | 725.04% | 670.97% | 1,859.79% |
| Change in Net Operating Assets | -59.06% | 72.92% | 1,315.16% | -12.36% | 614.21% |
| Cash from Operations | -111.44% | -99.93% | -109.43% | -207.23% | -102.24% |
| Capital Expenditure | -- | 41.94% | -1,071.43% | -22.41% | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 48.40% | -100.00% | -680.86% | 100.00% | 175.40% |
| Cash from Investing | 47.80% | -100.15% | -681.15% | 99.93% | 175.37% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 10,299.55% | -50.54% | 64,519.48% | -87.91% | -98.89% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 10,299.55% | -50.54% | 2,530.21% | -83.44% | -98.89% |
| Foreign Exchange rate Adjustments | -98.36% | -150.00% | 82.41% | -80.70% | 408.33% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 262.32% | -211.34% | -219.88% | -190.77% | 362.80% |